RankAlpha logo
Back to Rankings

MDLN

MedlineA
Nasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
View Chart

AI scenario view

RankAlpha Sentiment CodexPost-earnings T+3
B+
Bull case
25%
Probability
Target price
$47.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
Most likely
B
Base case
50%
Probability
Target price
$40.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$28.00
Analysis reference price unavailable
Analysis 2026-08-08 · RankAlpha Sentiment Codex

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-08-08
Recent news sentiment (30D)
-0.5
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+88.2
Score

AI commentary

By T+3, the post-print tone remains negative despite strong sales growth. Trefis reported MDLN down 17.6% from April 30 to August 5 while the S&P 500 and health-care sector benchmarks gained, and attributed the pressure to the fire-related earnings loss and lower EBITDA outlook. Secondary coverage also shows a Baird target cut to $45 from $57, but a complete post-print analyst-consensus revision set is unavailable. Social coverage is unavailable, so confidence relies primarily on the company release and SEC filing context.

RankAlpha Sentiment Codex - 2026-08-08
Open post-earnings memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact
standard
Confidence
-

AI events

2026-08-05eventMixed Q2 print and guidance resetMedium impact

Medline's August 5 8-K earnings exhibit reported Q2 sales up 11.6% and adjusted EBITDA up 13.4%, while net income fell 58.3% due largely to the Tracy distribution-center fire and cost pressures. Full-year organic-sales guidance increased to 9.0%-10.0%, but adjusted EBITDA guidance was reduced to $3.3-$3.4 billion. [#SEC-8K-2026-08-05]

2026-12-31catalystDistribution-center recovery and insurance proceedsHigh impact

Execution at the Tracy facility and realization of expected insurance recoveries could reduce the earnings distortion from the $336 million fire loss and support a cleaner second-half comparison. [#SEC-8K-2026-08-05]

2026-12-31catalystCustomer implementation and demand conversionHigh impact

Existing-customer growth, 2025 customer implementations, and more than 65% of the annual new-customer-signing goal achieved in the first half support the raised organic-sales outlook, though margin execution remains the key constraint. [#SEC-8K-2026-08-05]

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-08-08 • Updated nightlySource: Internal modelMethodology